22 November 2010: Sphere Medical, the UK-based medical sensor innovator, has achieved CE Marking for their Pelorus 1000 propofol measurement system, which offers the unique capability to rapidly measure concentrations of the intravenous anaesthetic propofol in whole blood samples.
Propofol is widely used in critical care, for general anaesthesia in the operating room and for sedation in the intensive care unit. At the present time, the concentration of intravenous anaesthetics in the blood stream cannot be measured in real time. The ability to titrate propofol to whole blood concentration is expected to be a key tool in individualising and optimising therapy at the patient level, both in the operating room and the intensive care unit.
The Pelorus 1000 offers the clinical researcher, for the first time, the ability to carry out studies which require real time drug concentration measurement, rather than retrospective sample analysis.
Stuart Hendry, CEO of Sphere Medical, said: “I am extremely pleased that Sphere has been able to bring this innovation to the market following successful clinical trials earlier this year, some of which were published at the ASA. We are already working with leaders in the critical care field and I look forward with anticipation to the studies being performed that will begin prove the clinical and economic benefits of real time measurement of propofol concentration.”
About Sphere Medical
Sphere Medical is developing highly innovative monitoring products to provide clinical and economic benefits in the critical care environment, based on the company’s proprietary microsensor technology. The products allow minimally invasive, real time measurement of clinical chemistry parameters and therapeutic drug concentrations, giving healthcare professionals the information they require to more effectively manage therapy and optimise patient outcomes. Sphere Medical was founded in 2002 and is based in Cambridge, UK.
For more information, please visit www.spheremedical.com, or contact:
Dr. Stuart Hendry Tim Anderson Chief Executive Officer Buchanan Communications Sphere Medical Holding PLC Tel: +44 (0) 20 7466 5000 Tel: +44 (0)1223 875222
sphere
For our Internet Broadcasting services please visit our main website
Buchanan Communications Reg. in Eng. No. 1499986 45 Moorfields London EC2Y9AE Vat No. GB 245 7021 77
